• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用质子核磁共振波谱法对卵巢肿瘤囊液进行代谢组学分析。

Metabonomic analysis of ovarian tumour cyst fluid by proton nuclear magnetic resonance spectroscopy.

作者信息

Kyriakides Michael, Rama Nona, Sidhu Jasmin, Gabra Hani, Keun Hector C, El-Bahrawy Mona

机构信息

Department of Surgery and Cancer, Imperial College London, London, United Kingdom.

Department of Histopathology, Hammersmith Hospital, Imperial College London, London, United Kingdom.

出版信息

Oncotarget. 2016 Feb 9;7(6):7216-26. doi: 10.18632/oncotarget.6891.

DOI:10.18632/oncotarget.6891
PMID:26769844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4872780/
Abstract

The majority of ovarian tumours are of the epithelial type, which can be sub classified as benign, borderline or malignant. Epithelial tumours usually have cystic spaces filled with cyst fluid, the metabolic profile of which reflects the metabolic activity of the tumour cells, due to their close proximity. The approach of metabonomics using 1H-NMR spectroscopy was employed to characterize the metabolic profiles of ovarian cyst fluid samples (n = 23) from benign, borderline and malignant ovarian tumours in order to shed more light into ovarian tumour and cancer development. The analysis revealed that citrate was elevated in benign versus malignant tumours, while the amino acid lysine was elevated in malignant versus non-malignant tumours, both at a 5% significance level. Choline and lactate also had progressively increasing levels from benign to borderline to malignant samples. Finally, hypoxanthine was detected exclusively in a sub-cohort of the malignant tumours. This metabonomic study demonstrates that ovarian cyst fluid samples have potential to be used to distinguish between the different types of ovarian epithelial tumours. Furthermore, the respective metabolic profiles contain mechanistic information which could help identify biomarkers and therapeutic targets for ovarian tumours.

摘要

大多数卵巢肿瘤是上皮类型的,可进一步细分为良性、交界性或恶性。上皮性肿瘤通常有充满囊液的囊腔,由于囊液与肿瘤细胞 proximity 接近,其代谢谱反映了肿瘤细胞的代谢活性。采用基于1H-NMR光谱的代谢组学方法对来自良性、交界性和恶性卵巢肿瘤的卵巢囊液样本(n = 23)的代谢谱进行表征,以便更深入地了解卵巢肿瘤和癌症的发展。分析显示,与恶性肿瘤相比,良性肿瘤中柠檬酸盐升高,而与非恶性肿瘤相比,恶性肿瘤中氨基酸赖氨酸升高,两者均在5%的显著性水平。从良性样本到交界性样本再到恶性样本,胆碱和乳酸水平也逐渐升高。最后,仅在一部分恶性肿瘤中检测到次黄嘌呤。这项代谢组学研究表明,卵巢囊液样本有潜力用于区分不同类型的卵巢上皮性肿瘤。此外,各自的代谢谱包含有助于识别卵巢肿瘤生物标志物和治疗靶点的机制信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4659/4872780/fad390d349ab/oncotarget-07-7216-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4659/4872780/f8078a183145/oncotarget-07-7216-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4659/4872780/fcc7240a2ea0/oncotarget-07-7216-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4659/4872780/7ac8870b5cd5/oncotarget-07-7216-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4659/4872780/fad390d349ab/oncotarget-07-7216-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4659/4872780/f8078a183145/oncotarget-07-7216-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4659/4872780/fcc7240a2ea0/oncotarget-07-7216-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4659/4872780/7ac8870b5cd5/oncotarget-07-7216-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4659/4872780/fad390d349ab/oncotarget-07-7216-g004.jpg

相似文献

1
Metabonomic analysis of ovarian tumour cyst fluid by proton nuclear magnetic resonance spectroscopy.采用质子核磁共振波谱法对卵巢肿瘤囊液进行代谢组学分析。
Oncotarget. 2016 Feb 9;7(6):7216-26. doi: 10.18632/oncotarget.6891.
2
MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome.MAL2 和肿瘤蛋白 D52(TPD52)在卵巢癌中经常过表达,但与组织学亚型和患者预后相关。
BMC Cancer. 2010 Sep 17;10:497. doi: 10.1186/1471-2407-10-497.
3
Differential expression of IL-8 and IL-8 receptors in benign, borderline and malignant ovarian epithelial tumours.白细胞介素-8 和白细胞介素-8 受体在良性、交界性和恶性卵巢上皮性肿瘤中的差异表达。
Cytokine. 2013 Oct;64(1):413-21. doi: 10.1016/j.cyto.2013.05.006. Epub 2013 May 30.
4
The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian Tumors.黏液性和浆液性上皮性卵巢肿瘤中黏蛋白型糖蛋白上的O-连接糖组与ABO血型抗原
PLoS One. 2015 Jun 15;10(6):e0130197. doi: 10.1371/journal.pone.0130197. eCollection 2015.
5
Pattern of tissue expression of CA-125 and HE4 in primary epithelial ovarian tumours and correlation with serum CA-125 levels.CA-125和HE4在原发性上皮性卵巢肿瘤中的组织表达模式及其与血清CA-125水平的相关性。
Asian Pac J Cancer Prev. 2013;14(8):4545-8. doi: 10.7314/apjcp.2013.14.8.4545.
6
MDM2 Expression in Serous and Mucinous Epithelial Tumours of the Ovary.MDM2在卵巢浆液性和黏液性上皮肿瘤中的表达
Asian Pac J Cancer Prev. 2016;17(7):3295-300.
7
EphA8 is a prognostic marker for epithelial ovarian cancer.EphA8是上皮性卵巢癌的一个预后标志物。
Oncotarget. 2016 Apr 12;7(15):20801-9. doi: 10.18632/oncotarget.8018.
8
Ovarian tumours of different histologic type and clinical stage induce similar changes in lipid metabolism.不同组织学类型和临床阶段的卵巢肿瘤会引起相似的脂代谢变化。
Br J Cancer. 2018 Oct;119(7):847-854. doi: 10.1038/s41416-018-0270-z. Epub 2018 Oct 8.
9
Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients.评估上皮性卵巢癌患者血浆、腹腔积液和肿瘤组织中间皮素水平的临床病理相关性。
Tumour Biol. 2018 Oct;40(10):1010428318804937. doi: 10.1177/1010428318804937.
10
Weapons ovarian epithelial tumors may use in immune escape: an immunohistochemical correlational study.卵巢上皮性肿瘤可能用于免疫逃逸的武器:一项免疫组织化学相关性研究。
Pathol Oncol Res. 2012 Apr;18(2):509-18. doi: 10.1007/s12253-011-9474-8. Epub 2011 Dec 8.

引用本文的文献

1
Peripheral Blood Serum NMR Metabolomics Is a Powerful Tool to Discriminate Benign and Malignant Ovarian Tumors.外周血血清核磁共振代谢组学是鉴别卵巢良恶性肿瘤的有力工具。
Metabolites. 2023 Sep 1;13(9):989. doi: 10.3390/metabo13090989.
2
AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma.血管正常化因子3TSR和Fc3TSR以及抗血管生成的贝伐单抗的腺相关病毒载体表达可延长晚期上皮性卵巢癌小鼠模型的生存期。
Biomedicines. 2022 Feb 2;10(2):362. doi: 10.3390/biomedicines10020362.
3
ADNEX Model-Based Diagnosis of Ovarian Cancer Using MRI Images.

本文引用的文献

1
Large-scale profiling of metabolic dysregulation in ovarian cancer.卵巢癌代谢失调的大规模分析
Int J Cancer. 2015 Feb 1;136(3):516-26. doi: 10.1002/ijc.29010. Epub 2014 Jun 17.
2
Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling.通过尿代谢组学分析鉴定卵巢癌的潜在生物标志物。
J Proteome Res. 2013 Jan 4;12(1):505-12. doi: 10.1021/pr3009572. Epub 2012 Dec 3.
3
Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry.
基于 ADNEX 模型的 MRI 图像卵巢癌诊断
Contrast Media Mol Imaging. 2021 Aug 18;2021:2146578. doi: 10.1155/2021/2146578. eCollection 2021.
4
The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling.微生物组在卵巢癌中的作用:共生肿瘤发生和细菌代谢产物信号转导的机制见解。
Mol Med. 2021 Apr 1;27(1):33. doi: 10.1186/s10020-021-00295-2.
5
Emerging Role of Metabolomics in Ovarian Cancer Diagnosis.代谢组学在卵巢癌诊断中的新兴作用
Metabolites. 2020 Oct 19;10(10):419. doi: 10.3390/metabo10100419.
6
H-NMR spectroscopy metabonomics of reactive, ovarian carcinoma and hepatocellular carcinoma ascites.反应性、卵巢癌和肝细胞癌腹水的氢核磁共振波谱代谢组学
Pleura Peritoneum. 2020 May 12;5(2):20200113. doi: 10.1515/pp-2020-0113. eCollection 2020 Jun 1.
7
Blood Metabolites Associate with Prognosis in Endometrial Cancer.血液代谢物与子宫内膜癌预后相关。
Metabolites. 2019 Dec 14;9(12):302. doi: 10.3390/metabo9120302.
8
Plasma metabonomics investigation reveals involvement of fatty acid oxidation in hematotoxicity in Chinese benzene-exposed workers with low white blood cell count.血浆代谢组学研究揭示了低白细胞计数的中国苯暴露工人血液毒性中脂肪酸氧化的参与。
Environ Sci Pollut Res Int. 2018 Nov;25(32):32506-32514. doi: 10.1007/s11356-018-3160-2. Epub 2018 Sep 20.
9
Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer.利用 MALDI-TOF 和三重四极杆飞行时间质谱联用技术进行血清代谢物分析,以开发卵巢癌筛查方法。
Cancer Res Treat. 2018 Jul;50(3):883-893. doi: 10.4143/crt.2017.275. Epub 2017 Sep 18.
10
Metabolomics of biomarker discovery in ovarian cancer: a systematic review of the current literature.卵巢癌生物标志物发现的代谢组学:当前文献的系统综述
Metabolomics. 2016 Apr;12(4). doi: 10.1007/s11306-016-0990-0. Epub 2016 Mar 8.
采用超高效液相色谱/质谱联用技术进行血浆代谢组学分析对良恶性卵巢肿瘤的鉴别诊断。
Clin Chim Acta. 2012 May 18;413(9-10):861-8. doi: 10.1016/j.cca.2012.01.026. Epub 2012 Jan 30.
4
In vivo detection of choline in ovarian tumors using 3D magnetic resonance spectroscopy.利用 3D 磁共振波谱技术在体检测卵巢肿瘤中的胆碱。
Invest Radiol. 2011 Jun;46(6):377-82. doi: 10.1097/RLI.0b013e31821690ef.
5
Diagnosis of early stage ovarian cancer by 1H NMR metabonomics of serum explored by use of a microflow NMR probe.采用微流 NMR 探头的 1H NMR 代谢组学对血清进行早期卵巢癌诊断。
J Proteome Res. 2011 Apr 1;10(4):1765-71. doi: 10.1021/pr101050d. Epub 2011 Feb 22.
6
Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors.早期和晚期卵巢癌及卵巢良性肿瘤患者血清、腹水和囊液中的促炎及免疫抑制细胞因子
Neuro Endocrinol Lett. 2010;31(3):375-83.
7
Ovarian cyst fluid of serous ovarian tumors contains large quantities of the brain amino acid N-acetylaspartate.浆液性卵巢肿瘤的囊液中含有大量的脑氨基酸 N-乙酰天冬氨酸。
PLoS One. 2010 Apr 22;5(4):e10293. doi: 10.1371/journal.pone.0010293.
8
Identification of hypoxanthine as a urine marker for non-Hodgkin lymphoma by low-mass-ion profiling.通过低质量离子分析鉴定黄嘌呤作为非霍奇金淋巴瘤的尿液标志物。
BMC Cancer. 2010 Feb 23;10:55. doi: 10.1186/1471-2407-10-55.
9
GSTP1-1 in ovarian cyst fluid and disease outcome of patients with ovarian cancer.卵巢囊肿液中的GSTP1-1与卵巢癌患者的疾病转归
Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2176-81. doi: 10.1158/1055-9965.EPI-09-0098.
10
N-acetyl resonances in in vivo and in vitro NMR spectroscopy of cystic ovarian tumors.体内和体外 NMR 光谱学中囊性卵巢肿瘤的 N-乙酰共振。
NMR Biomed. 2009 Dec;22(10):1093-9. doi: 10.1002/nbm.1417.